Cargando…
Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19
We present an integrated analysis of the clinical measurements, immune cells, and plasma multi-omics of 139 COVID-19 patients representing all levels of disease severity, from serial blood draws collected during the first week of infection following diagnosis. We identify a major shift between mild...
Ejemplares similares
-
Multiple early factors anticipate post-acute COVID-19 sequelae
por: Su, Yapeng, et al.
Publicado: (2022) -
Characteristics and Factors Associated with COVID-19 Infection, Hospitalization, and Mortality Across Race and Ethnicity
por: Dai, Chengzhen L., et al.
Publicado: (2021) -
Characteristics and Factors Associated With Coronavirus Disease 2019 Infection, Hospitalization, and Mortality Across Race and Ethnicity
por: Dai, Chengzhen L, et al.
Publicado: (2021) -
Angiotensin-Converting Enzyme (ACE) Inhibitors May Moderate COVID-19 Hyperinflammatory Response: An Observational Study with Deep Immunophenotyping
por: Duvvuri, Venkata R., et al.
Publicado: (2022) -
Identifying Personalized Metabolic Signatures in Breast Cancer
por: Baloni, Priyanka, et al.
Publicado: (2020)